BIXINCA Trademark

Trademark Overview


On Wednesday, August 14, 2019, a trademark application was filed for BIXINCA with the United States Patent and Trademark Office. The USPTO has given the BIXINCA trademark a serial number of 79268414. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, July 15, 2022. This trademark is owned by Novartis AG. The BIXINCA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
bixinca

General Information


Serial Number79268414
Word MarkBIXINCA
Filing DateWednesday, August 14, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, July 15, 2022
Registration Number5974661
Registration DateTuesday, February 4, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, August 1, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, August 1, 2022DEATH OF INTERNATIONAL REGISTRATION
Monday, January 3, 2022INTERNATIONAL REGISTRATION RENEWED
Tuesday, August 24, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, August 24, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, May 22, 2020NOTIFICATION PROCESSED BY IB
Friday, May 15, 2020NOTIFICATION PROCESSED BY IB
Monday, March 23, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 23, 2020FINAL DISPOSITION PROCESSED
Thursday, March 5, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 4, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 30, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 16, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 10, 2019ASSIGNED TO LIE
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Monday, October 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 4, 2019ASSIGNED TO EXAMINER
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 27, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB